Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord

被引:76
|
作者
Beiche, F
Klein, T
Nüsing, R
Neuhuber, W
Goppelt-Struebe, M [1 ]
机构
[1] Univ Erlangen Nurnberg, Dept Med 4, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Anat, D-91054 Erlangen, Germany
[3] Univ Marburg, Dept Pediat, D-35037 Marburg, Germany
关键词
prostaglandin G/H synthase; spinal cord; prostaglandin E-2 receptor EP3; immunocytochemistry;
D O I
10.1016/S0165-5728(98)00061-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cyclooxygenase-2 (COX-2) is now considered to be the major constitutively expressed COX isozyme in the central nervous system. The present immunocytochemical study details localization of COX-2 immunoreactivity in rat spinal cord along with the expression of prostaglandin E-2 receptor subtype EP3. Prominent COX-2 staining was observed in the nuclear envelope of neurons throughout the spinal cord, especially in the superficial dorsal horn laminae and motoneurons of lamina IX, as well as in glial cells of the white matter. Expression of EP3 receptor was strictly confined to afferent terminal areas in the superficial dorsal horns. (C) 1998 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:26 / 34
页数:9
相关论文
共 50 条
  • [31] Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development
    Sung, YM
    He, GB
    Fischer, SM
    CANCER RESEARCH, 2005, 65 (20) : 9304 - 9311
  • [32] COX-2 derived prostaglandin E2 regulates renal cortical EP3 receptor expression
    Waldner, C
    Heise, G
    Heering, P
    Schrör, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R114 - R114
  • [33] Immunohistochemical localization of prostaglandin EP3 receptor in the rat nervous system
    Nakamura, K
    Kaneko, T
    Yamashita, Y
    Hasegawa, H
    Katoh, H
    Negishi, M
    JOURNAL OF COMPARATIVE NEUROLOGY, 2000, 421 (04) : 543 - 569
  • [34] Prostaglandin E2 and EP3 Activation Potentiate Human Platelet Responsiveness
    Rocca, Bianca
    Petrucci, Giovanna
    Patrono, Carlo
    CIRCULATION, 2009, 120 (18) : S1148 - S1148
  • [35] Prostaglandin E2 and EP3 activation potentiate human platelet responsiveness
    Rocca, B.
    Petrucci, G.
    Rutella, S.
    Pocaterra, D.
    De Cristofaro, R.
    Patrono, C.
    EUROPEAN HEART JOURNAL, 2010, 31 : 974 - 974
  • [36] Inhibition of the Prostaglandin E2 EP3 Receptor Does Not Affect Beta Adrenergic Signaling in the Heart
    Bryson, Timothy D.
    Pandrangi, Teja S.
    Khan, Safa Z.
    Xu, Jiang
    Peterson, Edward
    Harding, Pamela
    FASEB JOURNAL, 2018, 32 (01):
  • [37] Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney
    Norregaard, Rikke
    Kwon, Tae-Hwan
    Frokir, Jorgen
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2015, 34 (04) : 194 - 200
  • [38] Cyclooxygenase-2, prostaglandin E2 and acute myeloid leukemia
    Denizot, Yves
    CARCINOGENESIS, 2010, 31 (05) : 953 - 953
  • [39] The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease
    Noguchi, Kazuyuki
    Ishikawa, Isao
    PERIODONTOLOGY 2000, 2007, 43 : 85 - 101
  • [40] Antagonists of the EP3 Receptor for Prostaglandin E2 Are Novel Antiplatelet Agents That Do Not Prolong Bleeding
    Singh, Jasbir
    Zeller, Wayne
    Zhou, Nian
    Hategen, Georgeta
    Mishra, Rama
    Polozov, Alex
    Yu, Peng
    Onua, Emmanuel
    Zhang, Jun
    Zembower, David
    Kiselyov, Alex
    Ramirez, Jose L.
    Sigthorsson, Gudmundur
    Bjornsson, Jon Mar
    Thorsteinsdottir, Margret
    Andresson, Thorkell
    Bjarnadottir, Maria
    Magnusson, Olafur
    Fabre, Jean-Etienne
    Stefansson, Kari
    Gurney, Mark E.
    ACS CHEMICAL BIOLOGY, 2009, 4 (02) : 115 - 126